Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Price Vision Group has been a global leader in cornea and refractive surgery for over three decades. The group has conducted more than 160 clinical studies—including pivotal research that led to FDA approval of LASIK—and offers a comprehensive suite of advanced vision correction procedures. Their surgeons have performed more cornea transplants than any other practice in North America. Clinical outcomes for procedures like LASIK are excellent, with most patients achieving 20/20 vision or better.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Price Vision Group.